Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Burning Rock Biotech (BNR) Operating Margin: 2019-2025

Historic Operating Margin for Burning Rock Biotech (BNR) over the last 7 years, with Sep 2025 value amounting to -9.24%.

  • Burning Rock Biotech's Operating Margin fell 1186.00% to -9.24% in Q3 2025 from the same period last year, while for Sep 2025 it was -16.23%, marking a year-over-year increase of 4209.00%. This contributed to the annual value of -69.32% for FY2024, which is 5522.00% up from last year.
  • As of Q3 2025, Burning Rock Biotech's Operating Margin stood at -9.24%, which was up 1.03% from -9.34% recorded in Q2 2025.
  • Over the past 5 years, Burning Rock Biotech's Operating Margin peaked at 2.62% during Q3 2024, and registered a low of -203.45% during Q2 2022.
  • Moreover, its 3-year median value for Operating Margin was -82.06% (2024), whereas its average is -70.02%.
  • Its Operating Margin has fluctuated over the past 5 years, first tumbled by 9,049bps in 2021, then skyrocketed by 14,279bps in 2024.
  • Burning Rock Biotech's Operating Margin (Quarterly) stood at -170.61% in 2021, then tumbled by 1,234bps to -182.95% in 2022, then spiked by 6,297bps to -119.98% in 2023, then surged by 4,455bps to -75.43% in 2024, then tumbled by 1,186bps to -9.24% in 2025.
  • Its last three reported values are -9.24% in Q3 2025, -9.34% for Q2 2025, and -11.41% during Q1 2025.